Quick Answer
Bone Biologics Corp reported Operating Income of -$3.23 million for fiscal year 2025.
Bone Biologics Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$3.23M | +23.3% |
| 2024 | -$4.22M | +55.3% |
| 2023 | -$9.43M | -157.2% |
| 2022 | -$3.67M | -232.3% |
| 2021 | -$1.10M | -33.7% |
| 2020 | -$825.0K | +66.3% |
| 2019 | -$2.45M | +12.3% |
| 2018 | -$2.79M | -6.3% |
| 2017 | -$2.63M | +87.1% |
| 2016 | -$20.41M | -70.2% |
| 2015 | -$12.00M | -298.5% |
| 2014 | -$3.01M | -348.0% |
| 2013 | -$672.0K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$715.3K | +24.8% | +4.4% |
| June 30, 2025 | -$748.1K | +7.6% | +28.0% |
| March 31, 2025 | -$1.04M | -14.9% | -9.2% |
| September 30, 2024 | -$951.0K | +54.3% | -17.5% |
| June 30, 2024 | -$809.7K | +73.4% | +10.4% |
| March 31, 2024 | -$903.5K | +71.3% | +56.6% |
| September 30, 2023 | -$2.08M | -70.7% | +31.5% |
| June 30, 2023 | -$3.04M | -547.7% | +3.4% |
- Bone Biologics Corp showed an increase of +23.3% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, Bone Biologics Corp’s operating income has declined by 381.4% (from -$672.0 thousand to -$3.23 million).
- The most recent figure is from Bone Biologics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: